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UTILIZATION OF TELEPSYCHIATRY TO COMBAT THE OPIOID CRISIS IN THE
UNITED STATES
ABSTRACT
Introduction: In the past five years, the United States (U.S.) has experienced an unprecedented
epidemic of opioid misuse, abuse and overdose related death, leading to a national public health
crisis. Telepsychiatry along with medication-assisted treatment has been proposed as a viable
solution. The purpose of this research was to examine the field of telepsychiatry as a practical
means to combat the rapidly increasing opioid epidemic facing America and to determine the
effect of telepsychiatry utilization on access to treatment received in an outpatient medical
setting.
Methodology: The methodology for this study was a literature review including the use of the
PRISMA approach. Five electronic databases and five websites were utilized. Twenty-one total
sources were carefully selected and referenced.
Results: This literature review examined several studies pertaining to the utilization of
telepsychiatry for opioid addiction treatment. After analyzing research on access and quality of
telepsychiatry, the results have shown that telepsychiatry along with medication-assisted
treatment has been shown to increase access to opioid addiction treatment while maintaining
quality care for patients.
Discussion/Conclusion: Telepsychiatry has been shown to have a positive impact on the way
opioid addiction treatment has been delivered. Benefits of increased access and quality of
treatment are further discussed.
Key Words: Access, Quality, Rural, Telehealth, Telepsychiatry
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INTRODUCTION
In the past five years, the United States (U.S.) has experienced an unprecedented epidemic of
opioid misuse, abuse and overdose related deaths (Gerhart et al., 2020). From 2000 to 2017,
more than 700,000 Americans have died from an opioid-related drug overdose, equating to a sixfold increase in the death toll since 1999 (CDC, 2019). On average, more than 130 Americans
have died daily as a direct result of opioid overdosing (The National Institute on Drug Abuse,
2019). Furthermore, while nationwide, this epidemic has been increasing at an alarming rate, the
crisis has increased the greatest in rural areas, where the likelihood of opioid misuse has been
five times more than that in urban area counterparts (CDC, 2019). This rapidly exploding
epidemic has been attributed to the growing prevalence of chronic pain, combined with historical
changes in opioid prescribing patterns due to illicit fentanyl, heroin and other opioid abuse
(Gerhart et al., 2020).
Opioids have been defined as a class of drugs naturally found in the opium poppy plant,
or synthetically produced in a laboratory, that work to block pain signals in the nervous system
between the brain and the body leading to the production of feelings of pleasure and pain relief
(Johns Hopkins Medicine, 2019). Commonly prescribed opioids have included oxycodone,
methadone, hydrocodone, codeine and morphine, while illicitly abused synthetic opioids have
included heroin and fentanyl (Scholl, Seth, Kariisa, Wilson & Baldwin, 2018).
While opioids have been commonly prescribed to reduce pain, regular use of this class of
drugs has been proven to increase an individual’s tolerance and dependence, thus requiring
higher and more frequent dosing, known to have led to addiction or a use disorder (Johns
Hopkins Medicine, 2019). A use disorder has been defined as a pattern of opioid use that has
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been problematic to one’s well-being and has led to significant impairment or distress (National
Institute of Health, 2019). Roughly 29% of patients who have been prescribed opioids for
chronic pain have misused the drug, while 12% have consequently developed an opioid use
disorder (The National Institute on Drug Abuse, 2019).
In addition, when taken at high doses, opioids have been shown to restrict an individual’s
ability to breathe, known as respiratory depression, and when misused, have led to fatal
overdoses (National Institute of Health, 2019). Total drug overdoses in the United States
resulted in 70,237 deaths during 2017, with 47,600 (67.8%) of these involving opioids (Scholl et
al., 2018).
Opioid addiction, abuse and overdose has become a national public health crisis,
estimated to have annually cost the U.S. $78.5 billion, with healthcare and substance abuse
treatment accounting for $29 billion of that substantial sum (Mahmoud & Vogt, 2019). Thus,
novel and innovative solutions have been explored, including both psychiatric and medicine
assisted telehealth intervention. Telehealth has been defined by the World Health Organization
as the remote use of electronic communication technologies to support long-distance clinical
healthcare, health-related education, public health or health administration (Brandt & Hensley,
2012). Telepsychiatry, a specialized subset of telehealth, has been defined as the provision of
mental healthcare at a distance through real-time videoconferencing and may include care
consultation, supervision, or patient education (Crawford, Sunderji, Lopez & Soklaridis, 2016).
In terms of pharmacotherapy for opioid addiction, only two opioid agonists have been
approved by the U.S. Food and Drug Administration for treatment known as medication-assisted
treatment, methadone and buprenorphine (Crawford et al., 2016). Unsurprisingly, such
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medication-assisted treatment has congruently seen a sharp increase in demand, with a 900%
increase in usage from 2011, however, traditional psychiatric services have been unable to keep
up with such demand (Molfenter, Boyle, Holloway & Zwick, 2015). Thus, telepsychiatry along
with medication-assisted treatment has been proposed as a viable solution (Mahmoud & Vogt,
2019). Telepsychiatry has offered great potential for enhancing treatment and recovery for
people with opioid use disorder (Molfenter et al., 2015).
The purpose of this research was to examine the field of telepsychiatry as a viable means
to combat the rapidly increasing opioid epidemic facing America and to determine the effect of
telepsychiatry utilization on access to treatment received in an outpatient medical setting, as well
as to analyze the effect on patient outcomes.
METHODOLOGY
The primary hypothesis of this research study was that the utilization of telepsychiatry has
expanded treatment access to those suffering from opioid use disorder, especially for patients in
rural or underserved areas where treatment was not freely available. A secondary hypothesis
was that telepsychiatric treatment services have maintained quality received by patients, as
opposed to traditional face-to-face psychiatric services, which led to improved patient outcomes
in terms of long-term recovery rates.
The methodology for this research study was a literature review that included a semistructured interview with an expert clinician. The literature review was conducted in four
distinct stages including: 1) literature identification and collection, 2) literature analysis and 3)
the semi-structured interview and 4) conceptual framework.
Step 1: Literature Identification and Collection
4
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A mix of databases and online websites were used to assemble a collection of references.
The electronic databases of Academic Search Premier, Ebsco Host, Google Scholar, ProQuest
and PubMed were searched for keywords such as ‘telehealth’ OR ‘telepsychiatry’ AND ‘opioid’
OR ‘substance use’ OR ‘addiction’ AND ‘access’ OR ‘patient outcomes’ AND ‘rural’ OR
‘underserved.’ The reputable websites of the Centers for Disease Control and Prevention, the
National Institute on Drug Abuse, the National Institute of Health, the World Health
Organization and Johns Hopkins were also used.
Step 2: Literature Analysis
The inclusion criteria for searches was limited to articles published between 2005 and
2020 in the English language. Research studies including primary and secondary data, along
with original articles and reviews which were included. This search criterion provided a
considerable amount of reliable data that had been researched, reported and utilized throughout
the telepsychiatry and behavioral health industry. The literature search was conducted by HT
and validated by AC who acted as a secondary reviewer and verified the resources met the
research study inclusion and exclusion criteria.
After a thorough investigation using PRISMA, the most relevant data was collected and
employed. The search identified 310 relevant articles. Additionally, articles from other
reputable online sources (N=20) were included in the search. Articles were excluded, (N=275) if
they did not meet the inclusion criteria. Articles were included (N=55) if they depicted
utilization of telehealth services as a means to increase access to treatment for opioid addiction
or as a measure of patient outcomes. Of these 55 sources, (N=28) were subject to full text
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review. Subsequently, (N=20) were included throughout the text, with (N=9) plus the interview
included in the results and (N=11) included in the remaining sections (see Figure 1).
Step 3: Semi-Structured Interview
A semi-structured interview with an expert clinician well-versed in the utilization of
telehealth services was conducted on April 18th, 2020. This clinician was a physician who has
been involved with a telehealth company for many years as both a provider and medical director.
This interview received IRB approval before conduction. The interview was subsequently
conducted in-person in a face to face format without the use of a tape recorder. Electronic notes
were taken during the interview process by the interviewer and later reviewed and implemented
into the research. (See Appendix)
Step 4: Conceptual Framework
The conceptual framework for this research displays the process of telehealth integration
in terms of technology uptake and utilization in Figure 2 (Pijnen et.al, 2011). User requirements
along with proven prototyping of technology must be considered at the forefront to telehealth
integration into an existing system. However, telehealth technology development must
continually involve formative evaluation cycles. Adhering to this framework has led to
successful telehealth implementation for healthcare systems.
RESULTS
Increased Access to Opioid Treatment
A proposed benefit of any telehealth service has been to increase access to care for
patients, especially patients residing in rural or underserved areas (Lin et al., 2018). An analysis
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from 3,142 U.S. counties found that 46.4% of those areas lacked a publicly available health care
professionals who could both prescribe the two medications, buprenorphine and methadone,
used to treat opioid use disorder and to provide proper psychiatric treatment in terms of patient
education (Huskamp et al., 2019). Furthermore, this number was found to significantly increase
to 71.2% when only rural areas were examined (Huskamp et al., 2019).
However, researchers have projected that if academic medical centers, federal agencies,
and for-profit companies begin using telehealth, this number can be drastically decreased
(Huskamp et al., 2019). Using telehealth and telepsychiatry to combat opioid addiction has been
established as a means to improve patient care by improving therapy engagement and providing
additional sources of treatment that could help patients overcome transportation or distance
barriers (Huskamp et al., 2019).
In 2017, West Virginia University (WVU) created the Comprehensive Opioid Addiction
Treatment (COAT) Program (Zheng et al., 2017). This program was based at WVU in
Morgantown, West Virginia, but provided care by establishing the first remote clinic for opioid
addiction treatment to the rural area of Clay County, West Virginia (Zheng et al., 2017). This
rural area was located four hours away from Morgantown and lacked any healthcare providers
that were legally able to prescribe the needed medication-assisted treatment to the local
population (Zheng et al., 2017).
The COAT program required the 100 enlisted patients to participate in counseling,
therapy, a 12-step addiction procedure and a buprenorphine medication program, all via
telehealth services (Zheng et al., 2017). The results showed that the patients who received this
telehealth enabled treatment would not have been able to receive the buprenorphine drug needed
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to complete the program without the use of remote prescription monitoring via telehealth (Rubin,
2019).
A similar study conducted in rural Maryland found comparable results (Weintraub,
Greenblatt, Chang, Himelhoch, & Welsch, 2018). This study evaluated a program that provided
buprenorphine treatment to 177 patients at an outpatient treatment center in rural Maryland via
telehealth (Weintraub et al., 2018). Toxicological urine screening for use of opioids revealed the
following pattern, 65% (115/177) of the patients were opiate negative at initiation of treatment;
of the 173 patients still engaged in therapy at 1 week of treatment 78.6% (136/173) had opiate
negative toxicology; and of the 101 patients still engaged at 3 months of treatment, 86.1%
(87/101) remained opiate negative (Weintraub et al., 2018). This study further concluded that the
telehealth program was an adequate method to deliver opioid addiction treatment to underserved
rural areas that otherwise may not have had the opportunity to receive any form of treatment
(Weintraub et al., 2018).
According to an Expert in Telehealth services, who has been a medical director for a
telehealth company for the past three years, this technology has provided increased access to
mental health, psychiatric and medication-assisted treatment for the American population and
specifically for those underserved. Around 70% of patients needing treatment for addiction
disorders have difficulty in receiving treatment in terms of logistics (Expert in telehealth, 2020).
Furthermore, over 80% of patients receiving traditional face-to-face care claim they are unhappy
with their healthcare (Expert in telehealth, 2020). According to the expert, telepsychiatry has
been the perfect platform to increase access to treatment, as much of the consultation has
revolved around education and talk therapy. This type of therapy, combined with medication,
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has the potential to greatly increase access to care with the hopes of eventually decreasing the
burden of opioid addiction to society (Expert in telehealth, 2020),
Improved Patient Outcomes
Opponents to the use of telehealth for treatment purposes have often stated the fear of
reduced quality of care thus leading to poor patient outcomes (Lin et al., 2019). However, a 2year retrospective study initiated by West Virginia University researchers and published in 2017,
found no difference in outcomes between patients receiving opioid use disorder treatment
through telehealth or from face-to-face encounters (Rubin, 2019). Similar studies conducted by
the University of Maryland and the University of Kentucky echoed these findings, further
emphasizing the appropriateness of virtual treatment (Rubin, 2019).
Moreover, other studies have found that patient outcomes are not only maintained but
furthermore improved when using a telehealth-based treatment platform (Lin et al., 2019). The
National Drug Abuse Treatment Clinical Trials Network conducted a retrospective study in
which they contrasted telepsychiatry addiction treatment with traditional face-to-face treatment
for 107 studies (Marsch et al., 2020). In a trial conducted in 2019, 135 patients were randomly
assigned to receive either 12 weeks of standard outpatient use disorder treatment or a model in
which telehealth was incorporated via 2 hours of weekly telehealth therapy and psychoeducation
(Marsch et al., 2020). The authors found that participants who received the telehealth treatment
as part of their care model had a markedly lower rate of treatment dropout, from 50% versus
78% of those patients solely enrolled in traditional in-person therapy (Marsch et al., 2020).
Furthermore, the telehealth patients had a higher rate of drug abstinence measured via a drug
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urine test of 49% versus 39% abstinence rate for those receiving traditional treatment (Marsch et
al., 2020).
However, an important caveat that has been documented when using telehealth
technologies has been the possibility of participant dropout due to technical difficulties (King,
Brooner, Peirce, Kolodner, & Kidorf, 2014). In a study that consisted of 12 weeks of
telepsychiatric sessions via internet-based videoconferencing for 85 patients, 26 patients were
noted to have withdrawn from the telehealth program, stating frustration with technology as the
main cause (King et al., 2014). However, it is worth noting, that since that study, significant
advances in technology and an importance placed on user-friendliness, have led to increased
participant retention rates (Ho & Argaez, 2019).
DISCUSSION
The purpose of this research was to examine the field of telepsychiatry as a viable means to
combat the rapidly increasing opioid epidemic facing America and to determine the effect of
telepsychiatry utilization on access to treatment received in an outpatient medical setting. The
results of the literature review and the interview with an expert in the field have demonstrated
that telepsychiatry has indeed had a positive effect on the access to treatment for opioid addicted
individuals. This literature review supports the use of telepsychiatry as an appropriate means of
psychiatric and medication-assisted treatment for individuals struggling with opioid abuse, use
disorder and addiction.
With a high prevalence of opioid addiction disorders in the US, adequate treatment is
imperative. However, as the prevalence of individuals suffering from opioid addiction has risen,
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the availability of treatment has not. Thus, telepsychiatry has offered a unique solution, allowing
more patients to receive treatment that otherwise may not have the access or the option to do so.
According to the Expert in telehealth services, telepsychiatry has incredible promise and
potential to help those suffering from opioid addiction. With the future economic burden
combined with increasing unemployment, the number of individuals battling addiction may
increase. This has historically shown to be problematic, as the already overworked healthcare
system cannot handle more treatment in terms of physicians and support. Thus, the Expert has
predicted that telepsychiatry used in combination with medication-assisted treatment, will see a
further increase in utilization. In fact, the Expert has predicted that this will become the main
way to provide addiction treatment in the future.
This research was not without its limitations. The literature review was limited due to the
search strategy employed to find sources, such has the number of databases. In an effort to find
relevant information, articles were limited to telepsychiatry, and mainly searches were conducted
to find articles that supported increasing the access of care through the use of telepsychiatry.
With this method, articles could have been filtered out from the searches and that information
would not have been accessed or used. Furthermore, in all the information that was utilized,
there was the possibility of publisher or researcher bias. Publishers of the case studies could
have only utilized surveys that would cater to supporting their claims. Additionally, researcher
bias could have played a role as well.
CONCLUSION
Telepsychiatry has been shown to have a positive impact on the way opioid addiction treatment
has been delivered. This literature review has indicated that utilization of telepsychiatry has
11
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increased the access of specialized addiction treatment to those in rural or underserved areas
while maintaining, or even improving, patient outcomes. Thus, both the primary and secondary
hypotheses have been supported by this literature research

12

Haley Tallarico – April 27, 2020 – HCA 695 – Final Draft
Figure 1. Overview of Literature Evaluation, PRISMA
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Figure 2. Conceptual Framework
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APPENDIX A
Questions Asked in Semi-Structured Interview of an Expert in Telehealth and Addiction
•

How have you seen the opioid epidemic affect patients and society in recent years? Why?

•

What traditional methods are best equipped to combat drug addiction, specifically opioid
addiction? Why?

•

How have you seen telehealth and specifically telepsychiatry expand on services
provided to patients? Why?

•

What is involved in a typical telehealth consultation?

•

Do you think patients who undergo telehealth treatment for addiction have positive
outcomes and are able to overcome their addictions? Why or Why not?

•

Have patients reacted well to telehealth experiences as opposed to in-person
consultations? Why or why not?

•

How do you feel telehealth can benefit patients struggling with addiction? Why?

•

What are some of the disadvantages of using telehealth for both patients and providers?
Why?

•

How do you think telehealth has impacted rural access to care? Why?

•

What do you feel is the future of telehealth usage for addiction? Why?
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